522 related articles for article (PubMed ID: 34082089)
1. Comparison of Roche and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19.
Hirotsu Y; Sugiura H; Maejima M; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M
Int J Infect Dis; 2021 Jul; 108():263-269. PubMed ID: 34082089
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: Comparison with RT-qPCR.
Hirotsu Y; Maejima M; Shibusawa M; Amemiya K; Nagakubo Y; Hosaka K; Sueki H; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M
Int J Infect Dis; 2021 Apr; 105():7-14. PubMed ID: 33556612
[TBL] [Abstract][Full Text] [Related]
3. Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients.
Hirotsu Y; Maejima M; Shibusawa M; Nagakubo Y; Hosaka K; Amemiya K; Sueki H; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Yagi S; Kojima S; Omata M
Int J Infect Dis; 2020 Oct; 99():397-402. PubMed ID: 32800855
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Lumipulse® G SARS-CoV-2 antigen assay automated test for detecting SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening.
Gili A; Paggi R; Russo C; Cenci E; Pietrella D; Graziani A; Stracci F; Mencacci A
Int J Infect Dis; 2021 Apr; 105():391-396. PubMed ID: 33647511
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Allplex™ SARS-CoV-2 Assay, Easy SARS-CoV-2 WE and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19.
Sberna G; Basile F; Guarino ML; Capobianchi MR; Bordi L; Parisi G
Int J Infect Dis; 2021 Dec; 113():113-115. PubMed ID: 34597768
[TBL] [Abstract][Full Text] [Related]
6. Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern.
Osterman A; Iglhaut M; Lehner A; Späth P; Stern M; Autenrieth H; Muenchhoff M; Graf A; Krebs S; Blum H; Baiker A; Grzimek-Koschewa N; Protzer U; Kaderali L; Baldauf HM; Keppler OT
Med Microbiol Immunol; 2021 Dec; 210(5-6):263-275. PubMed ID: 34415422
[TBL] [Abstract][Full Text] [Related]
7. Lumipulse G SARS-CoV-2 Ag assay evaluation using clinical samples from different testing groups.
Menchinelli G; Bordi L; Liotti FM; Palucci I; Capobianchi MR; Sberna G; Lalle E; Romano L; De Angelis G; Marchetti S; Sanguinetti M; Cattani P; Posteraro B
Clin Chem Lab Med; 2021 Jul; 59(8):1468-1476. PubMed ID: 33823089
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the field performance of multiple SARS-Cov-2 antigen rapid tests using nasopharyngeal swab samples.
Nóra M; Déri D; Veres DS; Kis Z; Barcsay E; Pályi B
PLoS One; 2022; 17(2):e0262399. PubMed ID: 35157700
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen Test.
Matsuzaki N; Orihara Y; Kodana M; Kitagawa Y; Matsuoka M; Kawamura R; Takeuchi S; Imai K; Tarumoto N; Maesaki S; Maeda T
J Med Virol; 2021 Dec; 93(12):6778-6781. PubMed ID: 34170555
[TBL] [Abstract][Full Text] [Related]
10. Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand.
Chaimayo C; Kaewnaphan B; Tanlieng N; Athipanyasilp N; Sirijatuphat R; Chayakulkeeree M; Angkasekwinai N; Sutthent R; Puangpunngam N; Tharmviboonsri T; Pongraweewan O; Chuthapisith S; Sirivatanauksorn Y; Kantakamalakul W; Horthongkham N
Virol J; 2020 Nov; 17(1):177. PubMed ID: 33187528
[TBL] [Abstract][Full Text] [Related]
11. Direct comparison of Xpert Xpress, FilmArray Respiratory Panel, Lumipulse antigen test, and RT-qPCR in 165 nasopharyngeal swabs.
Hirotsu Y; Maejima M; Shibusawa M; Natori Y; Nagakubo Y; Hosaka K; Sueki H; Amemiya K; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M
BMC Infect Dis; 2022 Mar; 22(1):221. PubMed ID: 35246055
[TBL] [Abstract][Full Text] [Related]
12. Clinical validation of quantitative SARS-CoV-2 antigen assays to estimate SARS-CoV-2 viral loads in nasopharyngeal swabs.
Aoki K; Nagasawa T; Ishii Y; Yagi S; Okuma S; Kashiwagi K; Maeda T; Miyazaki T; Yoshizawa S; Tateda K
J Infect Chemother; 2021 Apr; 27(4):613-616. PubMed ID: 33423918
[TBL] [Abstract][Full Text] [Related]
13. Evaluating a novel, highly sensitive, and quantitative reagent for detecting SARS-CoV-2 antigen.
Kobayashi R; Murai R; Asanuma K; Fujiya Y; Takahashi S
J Infect Chemother; 2021 Jun; 27(6):800-807. PubMed ID: 33546959
[TBL] [Abstract][Full Text] [Related]
14. Analysis of a persistent viral shedding patient infected with SARS-CoV-2 by RT-qPCR, FilmArray Respiratory Panel v2.1, and antigen detection.
Hirotsu Y; Maejima M; Shibusawa M; Amemiya K; Nagakubo Y; Hosaka K; Sueki H; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M
J Infect Chemother; 2021 Feb; 27(2):406-409. PubMed ID: 33183963
[TBL] [Abstract][Full Text] [Related]
15. Comparison of extraction-based and elution-based polymerase chain reaction testing, and automated and rapid antigen testing for the diagnosis of severe acute respiratory syndrome coronavirus 2.
Yoshioka N; Deguchi M; Hagiya H; Kagita M; Tsukamoto H; Takao M; Yoshida H; Hamaguchi S; Maeda I; Hidaka Y; Tomono K
J Med Virol; 2022 Jul; 94(7):3155-3159. PubMed ID: 35274327
[TBL] [Abstract][Full Text] [Related]
16. Clinical performance of Fujirebio Lumipulse G SARSCoV- 2 Ag chemiluminescent immunoassay.
Salvagno GL; Henry BM; De Nitto S; Pighi L; Lippi G
New Microbiol; 2022 Dec; 45(4):353-354. PubMed ID: 36538301
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Performance of Six Rapid Antigen Tests for SARS-CoV-2.
Navero-Castillejos J; Casals-Pascual C; Narváez S; Cuesta G; Hurtado JC; Fernandez M; Navarro M; Peiró-Mestres A; Lasheras MV; Rodriguez P; Pulgarín A; Marcos MÁ; Vila J; Martínez MJ
Microbiol Spectr; 2022 Apr; 10(2):e0235121. PubMed ID: 35293799
[TBL] [Abstract][Full Text] [Related]
18. The evaluation of a newly developed antigen test (QuickNavi™-COVID19 Ag) for SARS-CoV-2: A prospective observational study in Japan.
Takeuchi Y; Akashi Y; Kato D; Kuwahara M; Muramatsu S; Ueda A; Notake S; Nakamura K; Ishikawa H; Suzuki H
J Infect Chemother; 2021 Jun; 27(6):890-894. PubMed ID: 33727026
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Five Commercial SARS-CoV-2 Antigen Tests in a Clinical Setting.
Seitz T; Lickefett B; Traugott M; Pawelka E; Karolyi M; Baumgartner S; Jansen-Skoupy S; Atamaniuk J; Fritsche-Polanz R; Asenbaum J; Wenisch C; Födinger M; Zoufaly A
J Gen Intern Med; 2022 May; 37(6):1494-1500. PubMed ID: 35301660
[TBL] [Abstract][Full Text] [Related]
20. Analytical performance evaluation of Lumipulse® SARS-CoV-2 antigen assay in 392 asymptomatic patients.
Petruzziello A; Sabatino R; Catapane LA; De Falco C; Petti A; Tripaldelli E; Loquercio G; Annecchiarico A; Salzillo A; Caradonna E; Maggi P
J Clin Lab Anal; 2023 Mar; 37(6):e24867. PubMed ID: 36972465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
